Company

TRIMTECH Therapeutics Limited

Biotechnology Research Some of the Most Challenging Neurodegenerative and Inflammatory Diseases. 15 employees

Employees: 15
Contacts: 3
Emails: 3
Phones: 1

trimtechtherapeutics.com LinkedIn Crunchbase

TRIMTECH Therapeutics Limited Overview

Headquarters: Some of the Most Challenging Neurodegenerative and Inflammatory Diseases.
Website: trimtechtherapeutics.com
Industry: Biotechnology Research
Employees: 15
Founded: 2023
Funding: 31.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Technician jobs

About TRIMTECH Therapeutics Limited

TRIMTECH has a growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs and TRIMGLUEs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.

TRIMTECH Therapeutics Limited Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

TRIMTECH Therapeutics Limited Org Chart

Sample employees and titles

Name	Title	Location	Contact
Andrea Testa	Senior Director Chemistry - Trimtech	Cambridge, England, United Kingdom	Email Phone
Damian Crowther	Developing Therapies		View
Marie-Claire Peakman	Partner, Pfizer Ventures - Executive	United States	Email
Nicki Thompson	Biotech CEO, Company Builder, Director	United Kingdom	Email